טוען...
Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy
Serum albumin (SA) is used as a carrier to deliver cytotoxic agents to tumors via passive targeting. To further improve SA’s tumor targeting capacity, we sought to develop an approach to retain SA-drug conjugates within tumors through a combination of passive and active targeting. SA was recombinant...
שמור ב:
| הוצא לאור ב: | Sci Adv |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Association for the Advancement of Science
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6693903/ https://ncbi.nlm.nih.gov/pubmed/31453327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.aaw6081 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|